Cambridge Investment Research Advisors’s XPeng XPEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,555
Closed -$260K 3776
2025
Q1
$260K Buy
+12,555
New +$226K ﹤0.01% 2994
2022
Q3
Sell
-6,795
Closed -$216K 3174
2022
Q2
$216K Sell
6,795
-11,590
-63% -$298K ﹤0.01% 2674
2022
Q1
$507K Buy
18,385
+5,021
+38% +$178K ﹤0.01% 2088
2021
Q4
$673K Sell
13,364
-4,914
-27% -$222K ﹤0.01% 1868
2021
Q3
$650K Buy
18,278
+7,654
+72% +$304K ﹤0.01% 1841
2021
Q2
$472K Sell
10,624
-683
-6% -$23.3K ﹤0.01% 2100
2021
Q1
$413K Buy
+11,307
New +$470K ﹤0.01% 2029

Other funds holding XPEV

Cambridge Investment Research Advisors's XPEV Position: Q2 2025 in Review

Cambridge Investment Research Advisors sold out of XPeng (XPEV) in Q2 2025, closing a stake of 12,555 shares — an estimated $260K sold.

Cambridge Investment Research Advisors first reported a position in XPEV in Q1 2021 and held it in 7 quarters. The position peaked at $673K in Q4 2021. 216 funds tracked by Wall St. Rank hold XPEV as of Q2 2025.

  • Cambridge Investment Research Advisors reported no remaining XPeng position as of Q2 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 12,555 XPeng shares in Q2 2025, an estimated $260K.
  • Cambridge Investment Research Advisors first reported a position in XPeng in Q1 2021 and held it in 7 quarters.
  • Cambridge Investment Research Advisors's XPeng position peaked at $673K in Q4 2021.
  • 216 funds tracked by Wall St. Rank held XPeng as of Q2 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.